DH
Therapeutic Areas
AlveoGene Pipeline
| Drug | Indication | Phase |
|---|---|---|
| InGenuiTy™ Platform (rSIV.F/HN vector) | Platform for Rare Respiratory Diseases | Platform |
| Unnamed AATD Program | Alpha-1 Antitrypsin Deficiency (AATD) | Pre-clinical |
| CFTR Program (via Boehringer Ingelheim) | Cystic Fibrosis (CF) | Phase 1 |